Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research
about
Role of vascular smooth muscle cell in the inflammation of atherosclerosisHigh molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodelingAngiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate.Modulation of angiotensin II-induced inflammatory cytokines by the Epac1-Rap1A-NHE3 pathway: implications in renal tubular pathobiology.Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protectionAngiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs.Construction, expression and immunogenicity of a novel anti-hypertension angiotensin II vaccine based on hepatitis A virus-like particle.Effects of aqueous leaf extract of Asystasia gangetica on the blood pressure and heart rate in male spontaneously hypertensive Wistar ratsCan proteomics yield insight into aging aorta?Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.Early Training-Induced Reduction of Angiotensinogen in Autonomic Areas-The Main Effect of Exercise on Brain Renin-Angiotensin System in Hypertensive RatsPotential targets for intervention in radiation-induced heart disease.Angiotensin II Induced Cardiac Dysfunction on a Chip.The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell ProliferationPerinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.Antioxidants in kidney diseases: the impact of bardoxolone methyl.Angiotensin II accelerates mammary gland development independently of high blood pressure in pregnancy-associated hypertensive mice.Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinoprilCardiovascular reactivity after blockade of angiotensin AT1 receptors in the experimental model of tilting test in conscious rats.Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failureMechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertensionThe renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studiesThe importance of integrated risk management when treating patients with hypertension: benefits of angiotensin II receptor antagonist therapy.The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.Are renin-angiotensin-aldosterone system blockers distinguishable based on cardiovascular and renal outcomes in nephropathy?Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.Relationship of renin-angiotensin-aldosterone system polymorphisms and phenotypes to mortality in Chinese coronary atherosclerosis patients.New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy.Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.Angiotensin receptor blockers: pharmacology, efficacy, and safety.Aldosterone mediates cardiac fibrosis in the setting of hypertension.Angiotensin II receptor antagonists in acute coronary syndromes.Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system.Vascular smooth muscle cell in atherosclerosis.Radionuclide imaging of neurohormonal system of the heartRenin-angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention.Salt-sensitive hypertension: mechanisms and effects of dietary and other lifestyle factors.The adipose tissue and the involvement of the renin-angiotensin-aldosterone system in cardiometabolic syndrome.Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.Angiotensin-converting enzyme gene polymorphism and middle cerebral artery stenosis in a Chinese Han population.
P2860
Q26823875-F043E842-1B15-4139-B2A0-F8AB072A8684Q31161236-76489897-4CFC-4B39-B605-FFF194259577Q33554921-C9136F37-A611-4D8B-9EE5-6B50E9CA59D3Q33701556-2BE4FC9D-3588-4F55-8C5E-AC0AEC8B8069Q34068728-99A7A2BD-66D8-4DAE-93B2-F694204B9326Q34555953-FEDF28F4-A643-40BD-9453-24A752C3D970Q34587965-49B5A299-DC65-4589-A4C2-6B9971331069Q35026429-288F307A-3124-457E-8B83-12B57C96B817Q35598638-CECB9F4D-4780-4581-AA4D-E800F6F08829Q35726197-43BAE4A8-8E74-4914-BB11-478CB7C45E5BQ35776021-A83BD3D4-C757-4133-976E-4878E16D1B63Q35848543-7DE1CD00-301A-4C1B-8491-4353BF771F50Q35903561-AAC70A46-4D41-462B-88E1-4FA9C18DDEA7Q35908229-AD136CEB-CDE2-482A-9FDE-F208D25CB0F1Q35995112-9DABCD09-2371-4A1A-A96B-20245376D398Q36026304-FC2C7114-327D-4B9F-8BFF-8838FFEFFADEQ36144567-5B36FEDC-E406-4680-BCD2-2A2200830DE9Q36210118-FAED6BB2-C422-4DDA-8ED7-6E5026902402Q36495126-DA0B4794-8906-4CF5-B966-498544905E2CQ36612182-1167181B-E004-4311-95B2-48ECA8EE3A3CQ36753476-E9B75621-6459-431E-93DB-00F3E8465AD3Q37158159-43847144-BC08-48E1-963F-E1A6E459344DQ37218795-E25377BF-A1D4-42D3-A93E-606A221F5A46Q37363586-7004D643-9B47-403A-A00B-9DEB85E837CCQ37427247-169CDE2C-1F4B-45D4-89F5-0E54286286D4Q37505849-1AC24171-861E-4DCC-A6C7-000350FA7E12Q37697794-EB0AA361-14C0-4EC2-BFD3-F2F4E6D401FCQ37730859-975FE352-ECAF-4FAB-A86B-B6B3F1A3A6D5Q37798001-B6023028-E2AB-4FD9-A730-83A59E84DD5DQ37928133-0D8ABED2-A0E0-4697-BE9E-99D1C0EF7E72Q38107897-D9A184B3-FEEE-44D3-B7F5-6380A2D63A74Q38167346-391D7BC4-0446-40F8-BC5C-DBDAD73CB7C5Q38230104-743A7F1D-8645-47F7-A61C-0C9BD1A810A4Q38353932-34330554-0517-4E39-8CCF-448D02DBF57BQ38397104-0EF116C8-1014-4443-B898-859E6584F280Q38835716-C9381902-94CF-43E2-9A89-E829B73B2AA5Q38938546-41418DA4-7AEA-4998-8A15-358ECA62D656Q38979226-A74B190C-C25D-4248-9F35-9D946F3E7719Q39236911-29F36AED-99F1-4FAB-B426-D8A324A655EEQ39414064-2BE1C9B7-F77C-4003-904D-8234BD765C9C
P2860
Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Role of angiotensin II in card ...... ore than a century of research
@ast
Role of angiotensin II in card ...... ore than a century of research
@en
Role of angiotensin II in card ...... ore than a century of research
@nl
type
label
Role of angiotensin II in card ...... ore than a century of research
@ast
Role of angiotensin II in card ...... ore than a century of research
@en
Role of angiotensin II in card ...... ore than a century of research
@nl
prefLabel
Role of angiotensin II in card ...... ore than a century of research
@ast
Role of angiotensin II in card ...... ore than a century of research
@en
Role of angiotensin II in card ...... ore than a century of research
@nl
P2860
P356
P1476
Role of angiotensin II in card ...... ore than a century of research
@en
P2093
Carlos M Ferrario
P2860
P356
10.3317/JRAAS.2006.003
P407
P577
2006-03-01T00:00:00Z